Drug Design and Delivery for Intracellular Bacteria: Emerging Paradigms

Area of Science:

• Microbiology
• Pharmacology
• Nanotechnology

Background:

• Intracellular bacteria evade antibiotics by residing in host cell niches like lysosomes and cytosol.
• These niches present challenges such as acidic conditions, host membrane barriers, and drug efflux mechanisms.
• Current nanotechnologies for intracellular delivery often fail due to off-site targeting and degradation.

Purpose of the Study:

• To introduce a next-generation approach for intracellular antibacterial therapy.
• To address limitations of current strategies by incorporating advanced delivery and targeting mechanisms.
• To advocate for precise spatiotemporal regulation of drug activity within infected host cells.

Main Methods:

• Reviewing advancements in nanotechnology for drug delivery.
• Exploring subcellular targeting and dual-function delivery systems.
• Incorporating biomimetic carriers, PK/PD assessment, and AI-assisted drug design.
• Highlighting frameworks for multimodal regimens.

Main Results:

• Current strategies are limited by a narrow focus on cellular entry.
• Next-generation approaches emphasize subcellular targeting and controlled drug release.
• Multimodal regimens can be designed for precise intracellular regulation.
• AI can assist in designing novel antibacterial therapeutics.

Conclusions:

• A paradigm shift is needed from facilitating cellular entry to precise spatiotemporal regulation of drug activity.
• Therapeutics should be designed to persist within the intracellular bacterial niche.
• This approach aims to minimize relapse and reduce antimicrobial resistance emergence.